Company page
Monopar Therapeutics Inc.
Monopar Therapeutics Inc. is a public company traded under the ticker MNPR in the American market. The company has a market capitalization of approximately $736 million. Monopar focuses on developing innovative therapies for cancer treatment.
- Ticker
- MNPR:NASDAQ
- Asset type
- Stock
- Market cap
- $740.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD